We reported earlier that during chronic toxoplasmosis CD8 + T cells become functionally exhausted with concomitant PD-1 upregulation, leading to eventual host mortality. However, how immune exhaustion specifically mediates attrition of CD8 polyfunctionality, a hallmark of potent T-cell response, during persistent infections has not been addressed. In this study, we demonstrate that PD-1 is preferentially expressed on polyfunctional memory CD8 + T cells, which renders them susceptible to apoptosis. In vitro blockade of the PD-1-PD-L1 pathway dramatically reduces apoptosis of polyfunctional and interferon γ + /granzyme B − memory but not effector CD8 + T cells. In summary, the present report underscores the critical role of the PD-1-PD-L1 pathway in mediating attrition of this important CD8 + T-cell subset and addresses the mechanistic basis of how αPD-L1 therapy reinvigorates polyfunctional CD8 response during chronic infections. The conclusions of this study can have profound immunotherapeutic implications in combating recrudescent toxoplasmosis as well other chronic infections. 
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Effective CD8
+ T-cell response is critical for control of both acute and chronic Toxoplasma infection [1, 2] . Mice lacking CD8 + T cells exhibit inability to clear infection [3] , and depletion of CD8 + rather than CD4 + T cells had a greater effect on mortality of chronically infected animals [4] . Moreover, chronically infected susceptible mice strains show reduced number of intracerebral CD8 + T cells with concomitant toxoplasmic encephalitis (TE) development [5] . Combined, these studies underline the important role of this T-cell subset in controlling Toxoplasma infection during the chronic phase.
Interferon γ (IFN-γ) is critical for mediating protective immunity to Toxoplasma, and during chronic infection
CD8
+ T cells are a major source of this cytokine, which is essential for controlling parasite reactivation [6, 7] . CD8 + T cells can also provide effector function via production of other cytokines, including tumor necrosis factor α [3, 8] . However, macrophages but not CD8 + T cells are the major producers of this cytokine during chronic toxoplasmosis [9] . Similarly, multiple studies using replication-competent strains of Toxoplasma have demonstrated that T cells produce minimal interleukin 2 during both acute and chronic Toxoplasma infection [10] . Apart from cytokines, CD8-mediated cytotoxicity most likely plays an important role in controlling chronic toxoplasmosis [10] . A recent study has demonstrated that CD8 + T cells are capable of eradicating cysts in sulfadiazine-treated immunodeficient mice by a perforin-dependent mechanism [11] . Based on these findings, IFN-γ and cytotoxicity appear to be the critical effector mechanisms for CD8-mediated control of this protozoan. Pardoxically, robust CD8 + T-cell response during the acute phase of infection does not ensure long-term survival of susceptible mice [12] . Recent studies from our laboratory [13] demonstrated that CD8 + T cells from chronically infected mice exhibit progressive functional exhaustion, concomitant with increased expression of PD-1, an inhibitory receptor on their surface. This dysfunction results in reactivation of latent infection, which eventually leads to death of the infected animals. In vivo blockade of PD-1 interaction with its receptor PD-L1, reinvigorated polyfunctional CD8 + T-cell response (ie, the capacity for a single T cell to exhibit multiple functions) and prevented death of infected animals. Incidentally, the observation that human immunodeficiency virus (HIV)-infected nonprogressors are superior at maintaining virus-specific polyfunctional CD8 + T cells compared with HIV-infected progressors [14] suggests that this polyfunctional population constitutes an important part of protective immune response against intracellular pathogens. However, how immune exhaustion causes attrition of polyfunctional CD8 + T cells during chronic infections has not been addressed in parasitic or even in viral models of persistent infection. Considering the prevalence of TE in Toxoplasma-seropositive AIDS patients [15] , approaches that boost CD8 polyfunctionality can have profound implications against both HIV and Toxoplasma gondii infections. Despite wide Toxoplasma seropositivity in the global population, current initiatives for vaccine development against this parasite are prophylactic in nature [16] . Because the majority of the mortality caused by Toxoplasma is due to parasite reactivation in immunocompromised patients [17] , there is an urgent need for development of immunotherapeutic vaccination approaches to combat this infection. In this study, we report for the first time that PD-1 is preferentially expressed on polyfunctional memory phenotype CD8 + T cells, which renders them susceptible to apoptosis. In vitro blockade of this pathway reduced active caspase 3 expression on both polyfunctional and IFN-γ + /granzyme B − memory phenotype CD8 + T cells. Thus the current study highlights a critical and arguably novel mechanism of how the PD-1-PD-L1 pathway promotes the attrition of polyfunctional CD8 response. More important, from a therapeutic perspective, this creates a strong basis for incorporating anti-PD-L1 as an adjuvant in immunotherapeutic vaccination approaches against chronic toxoplasmosis.
MATERIALS AND METHODS

Mice, Parasites, and Toxoplasma Lysate Antigen Preparation
Female C57BL/6 mice (National Cancer Institute) aged 6-8 weeks were infected with 10 ME49 cysts via oral route. Animal studies were carried out in agreement with Institutional Animal Care and Use Committee-approved guidelines. Toxoplasma lysate antigen (TLA) was prepared from the RH strain of the parasite, as previously described [18] .
Lymphocyte Isolation, Cell Surface Staining, and Intracellular Staining
Single-cell suspension was prepared from spleen and brain using standard protocol. For direct ex vivo assessment of apoptosis, BD AnnexinV Kit was used as per manufacturer's protocol. Intracellular staining was performed after surface staining using Cytofix/Cytoperm Kit (BD Biosciences) as per manufacturer's protocol. For cytokine detection, restimulation was carried out for 16 hours with 30 μg/mL of TLA in supplemented media. For some samples, αPD-L1 (MIH5) antibody or isotype control antibody was added throughout the incubation period at a final concentration of 30 μg/mL.
Statistical Analysis
Statistical analysis was performed using Student t test with P < .05 considered statistically significant. Additional details are available in the Supplementary Methods.
RESULTS
Majority of Polyfunctional CD8
+ T Cells During Chronic
Toxoplasmosis Exhibit a Memory Phenotype
Toxoplasma infection induces a robust CD8 + T-cell response, which has been reported to be critical for protection against host infection [3] . However, during the late chronic phase, the parasite undergoes reactivation (ie, conversion from chronic stage-associated bradyzoite [slowly replicating, primarily encysted, relatively quiescent] to acute stage-associated tachyzoite [rapidly replicating]) [19] . Because IFN-γ has been shown to be critical for control of Toxoplasma [20] , we measured serum levels of IFN-γ as well as production of this cytokine by splenic CD8 + T cells. Concomitant with parasite reactivation, decreased serum IFN-γ levels ( Figure 1A ) and reduced IFN-γ production by CD8 + T cells ( Figure 1B) [24] . Because naive nonspecific CD8 + T cells also express CD127, we examined the phenotype in brain, a site that specifically recruits CD8 + T cells in a strictly
antigen-specific manner [25] . Contrary to our expectations based on the degree of attrition of polyfunctionality, we only noted moderate differences in the frequency of CD127 hi cells ( Figure 2A ). Although dramatic changes in the frequency of CD8 + /CD127 hi T cells were not noted in the brain, the absolute numbers of both effector and memory phenotype CD8 + T cells were reduced in the brain during the later phases of infection ( Figure 2B ).
Preferential Expression of PD-1 on Memory CD8 + T Cells
In a recent study, we reported that PD-1 hi /CD8 + T cells were preferentially apoptotic as evaluated by elevated active caspase 3 expression [13] . Based on this report and the finding that the frequency of memory phenotype CD8 + T cells were only moderately affected at the effector site during late chronic toxoplasmosis, we hypothesized that PD-1 was expressed both on memory and effector CD8 + T cells. Hence, next we Because a previous study using the acute infection−causing Lymphocytic choriomeningitis virus (LCMV) Armstrong strain had shown that CD43 (activation-associated isoform) expression can be used to discriminate effector (CD43 hi ) from memory (CD43 lo ) CD8 + T cells, we examined the expression of this molecule on CD8 + T cells in the spleen and brain [26] .
Polychromatic flow cytometry revealed that the majority of PD-1 hi cells in both tissues coexpressed CD43 and that increase in PD-1 expression correlated with increase in CD43 expression ( Figure 3A ). [23] . Surprisingly, despite elevated CD43 expression, the majority of PD-1 hi /CD43 hi cells in both tissues coexpressed high levels of CD44 and CD127 ( Figure 3B and 3C). In contrast, most cells in the other 3 subsets, irrespective of CD43 expression, exhibited lower frequency of CD127 hi cells ( Figure 3C ). To further verify memory/effector characteristics of PD-1-expressing CD8T cells, we evaluated various CD8 subsets for presence of Bcl-2, an antiapoptotic molecule that is expressed at high levels in memory CD8 + T cells [23, 27] . Figure 3D ). These findings suggest that although the PD-1 hi CD8 + T cells exhibit memory characteristics, they represent a phenotype distinct from both conventional memory and effector CD8 + T cells generated in acute infection models [26] .
Increased Expression of PD-1 Is Associated With Apoptosis of Polyfunctional Memory CD8 + T Cells
As mentioned previously, PD-1 hi /CD8 + T cells during chronic toxoplasmosis express high levels of active caspase 3 [13] . Because a previous study demonstrated that despite elevated active caspase 3 expression anergic T cells do not undergo apoptosis [28] , we wanted to revalidate our earlier findings by assessing the distribution of membrane phosphatidly serine using fluorochome-conjugated annexin V, which is considered a hallmark of apoptosis [29] . As shown in Figure 4A , the 
PD-1-PD-L1 Blockade Reduces Apoptosis of Polyfunctional and IFN-γ + /CD8 + T Cells
To directly link the role of increased PD-1 expression on polyfunctional memory CD8 + T cells with their apoptosis, we performed in vitro treatment of splenocytes with isotype control or αPD-L1 antibody (MIH5, blocking but nondepleting) [32] . The rationale for performing in vitro studies is that apoptotic cells get rapidly eliminated in vivo, and thus an accurate assessment of apoptosis cannot be made. In vitro incubation of TLA-stimulated splenocytes for 16 hours with αPD-L1 did not alter CD8 + T-cell functionality or proliferation, irrespective of the subset examined (data not shown). It is possible that with longer multiday incubation we may observe increase in polyfunctionality in αPD-L1 treated cells, akin to the in vivo scenario [33] . However, with longer incubations, CD8 + T cells in αPD-L1 treated groups may undergo rapid expansion and, as a result, it will not be possible to discriminate the differential effects of apoptosis and expansion on the various CD8 subsets [33] . As expected, αPD-L1 treatment had no effect on apoptosis of naive phenotype CD8 + T cells cells. Considering that IFN-γ is considered to be critical in mediating protection against Toxoplasma as well other pathogens [20] , the mechanistic insight offered by the current study can have important ramifications in incorporating αPD-L1 antibody in immunotherapeutic applications Figure 5 . In vitro αPD-L1 treatment prevents apoptosis of polyfunctional memory phenotype CD8 + T cells. Splenocytes from chronically infected (week 7) mice were treated with αPD-L1 and stimulated overnight with Toxoplasma lysate antigen. A, Active caspase 3 expression in various CD8 subsets in isotype and αPD-L1-treated splenocytes. 
DISCUSSION
Recent studies, primarily in viral models, have established T-cell polyfunctionality as a critical predictor of efficacious antiviral immune response and vaccine potency [34] . However, the role of polyfunctional CD8 + T cells in parasitic or bacterial infection models has not been thoroughly investigated. Unlike chronic viral models, in mycobacterial infection, disease progression is not associated with contraction of polyfunctional T cells [35] . This makes a pathogen-specific study of polyfunctionality and host morbidity and mortality critical for determining whether gain or loss of polyfunctionality is linked to pathogen clearance. In contrast, in the Toxoplasma model, as we have previously demonstrated [13, 36] and further reiterated in the current study, loss of polyfunctional CD8 + T cells is strongly associated with PD-1-mediated CD8 + exhaustion and recrudescence of disease. Moreover αPD-L1 treatment not only upregulated polyfunctional CD8 + T-cell response but also prevented parasite reactivation. Combined, this creates a strong basis for investigating how PD-1 mediates attrition of polyfunctional CD8 + T cells during chronic toxoplasmosis.
In this study, we demonstrate for the first time that during chronic toxoplasmosis, the majority of the polyfunctional CD8 + T cells exhibit a memory phenotype. Although PD-1-expressing memory phenotype polyfunctional CD8 + T cells were preferentially apoptotic, paradoxically, the proportion of memory CD8 + T cells at the effector site (brain) was not dramatically altered. Incidentally, in chronic infection models, there is a continuous recruitment of naive T cells, which contributes to the pathogen-specific T-cell response [37] . Based on our observation in the T. gondii model that the frequency of memory CD8 + T cells is not dramatically affected but they are preferentially apoptotic, it is tempting speculate that naive T cells recruited during the chronic phase preferentially differentiate to memory precursor effector cells. This hypothesis is further supported by the observation that inflammatory cytokines are reduced during chronic toxoplasmosis. Incidentally, reduced inflammation as shown by the Kaech lab [24] results in preferential differentiation to memory precursor effector CD8 + T cells. Hence, in future studies it will be important to address this issue using adoptive T-cell transfer approaches and partial bone marrow chimeras. However, the above hypothesis does not explain why the absolute numbers of both effector and memory CD8 + T cells are drastically reduced during chronic toxoplasmosis. One explanation could be reduced thymic output during chronic toxoplasmosis. Although thymic atrophy has been reported in the Toxoplasma model, its role on CD8 + T-cell response development and disease pathogenesis has not been extensively studied [38] . Apart from thymic atrophy, reduced effector or memory T-cell number could be a consequence of attenuated naive T-cell priming. As reported by our laboratory earlier, PD-L1, the receptor of PD-1, is also highly expressed during late chronic toxoplasmosis [13] . Incidentally, PD-L1 is expressed on both nonhematopoietic cells and hematopoietic cells, including antigen-presenting cells (APC) [39] . How PD-L1 expression on APC modulates their priming ability (costimulation, cytokines) has not been addressed in the Toxoplasma model. Apart from aforementioned effect on recent thymic emigrants, the possibility of antiapoptotic cytokines like interleukin 15 ( primarily produced by APC) [40, 41] directly affecting baseline survival of preexisting memory and effector cells independent of CD8-intrinsic PD-1 expression needs to be considered in future studies One of the hallmarks of robust CD8 + T-cell immunity is the capacity to mount a potent recall response [42] . As demonstrated by our laboratory previously, CD8 + T cells during the later stages of chronic infection are deficient in this regard [13] . Although high levels of active caspase 3 were also noted for polyfunctional effector CD8 + T cells, this subset exhibited minimal PD-1 expression. This suggests that apart from PD-1, other PD-1-independent, apoptosis-inducing mechanisms are at play. Considering that exhaustion in viral models has been associated with upregulation of multiple inhibitory receptors, the role of molecules such as Tim-3, 2B4, CTLA-4, Lag3, CD160, and others need to be investigated for their role in inducing apoptosis of polyfunctional CD8 + T cells [45] . subset remained refractory to the antiapoptotic effects of in vitro αPD-L1 treatment. As mentioned earlier, this may be due to coexpression of other inhibitory receptors, which may dampen the ameliorative effects of αPD-L1. Alternatively, this subset may require prolonged αPD-L1 treatment for reducing its apoptotic potential. These possibilities may not be mutually exclusive.
Reinvigoration of CD8 + T-cell response via αPD-L1 administration has profound significance for treatment of tumors and chronic infections such as hepatitis B, hepatitis C, and HIV [46, 47] . Development of a robust polyfunctional T-cell response is considered 1 of the hallmarks of potent antipathogen immunity. However, few reports have addressed the mechanistic basis for the development of polyfunctional response. A recent study demonstrated that strong antigen stimulation results in development of polyfunctional T-cell response [48] . However, in chronic infections where not only high antigen burden is present but also elevated levels of CD8 + T cell-expressed PD-1, polyfunctionality is lost. How the PD-1-PD-L1 pathway causes attrition of this polyfunctional response in chronic infections has not been investigated before. The current study strongly suggests that, not withstanding the per cell decrease in function, PD-1 expression on polyfunctional memory CD8 + T cells strongly predisposes them to apoptosis. Significantly, transient in vitro blockade of the PD-1-PD-L1 pathway is potent enough to reduce apoptosis of this important subset. Despite the reduction in apoptosis in αPD-L1-treated splenocytes, no dramatic change in Bcl-2 levels was noted in CD8 + T cells (data not shown). Although this suggests that blockade of the PD-1-PD-L1 pathway does not affect Bcl-2 expression, the role of specific antiapoptotic molecules, such as Bcl-xl, and pro-apoptotic molecules, such as Bak, Bax, Bid, Bim, and Bad, need to be considered in future studies [49] . In summary, the conclusions of this present report have profound implications for immunotherapeutic regimens targeting polyfunctional CD8 T-cell response against chronic infections.
Supplementary Data
Supplementary materials are available at the Journal of Infectious Diseases online (http://jid.oxfordjournals.org/). Supplementary materials consist of data provided by the author that are published to benefit the reader. The posted materials are not copyedited. The contents of all supplementary data are the sole responsibility of the authors. Questions or messages regarding errors should be addressed to the author.
Notes
